Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric antigen receptors recognizing cancer-specific TN glycopeptide variants

Chimeric antigen receptors recognizing cancer-specific TN glycopeptide variants

US Patent 10189908 · Granted Jan 29, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer treatment with 237 CAR-T cell based therapeutics recognizing the Tn epito2025
Chimeric antigen receptors and uses thereof2025
CD19 and CD22 chimeric antigen receptors and uses thereof2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025
Human mesothelin chimeric antigen receptors and uses thereof2024
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy2024
CD19 and CD22 chimeric antigen receptors and uses thereof2024
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 bin2024
Method of treating cancer by administering immune effector cells expressing a ch2024
Regulatable chimeric antigen receptor2023
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2022
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 bin2021